NB-CIPROFLOXACIN DIN 02567644
Status: Marketed
Holder: NB PHARMA INC.
Available to quote
Health Canada record
| Active ingredient(s) | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01MA02 CIPROFLOXACIN |
| Original market date | 15-Sep-2026 |
| Current status date | 15-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
NB Pharma Inc. — licence 3-002798, currently licensed, last inspection rating C (2025-12-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02247339 | ACT CIPROFLOXACIN | TEVA CANADA LIMITED | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02247340 | ACT CIPROFLOXACIN | TEVA CANADA LIMITED | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02247341 | ACT CIPROFLOXACIN | TEVA CANADA LIMITED | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Marketed |
| 02476606 | AG-CIPROFLOXACIN | ANGITA PHARMA INC. | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 02381907 | AURO-CIPROFLOXACIN | AURO PHARMA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02381931 | AURO-CIPROFLOXACIN | AURO PHARMA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 02381923 | AURO-CIPROFLOXACIN | AURO PHARMA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02444887 | BIO-CIPROFLOXACIN | BIOMED PHARMA | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02556502 | BIO-CIPROFLOXACIN | BIOMED PHARMA | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 01945270 | CILOXAN | NOVARTIS PHARMACEUTICALS CANADA INC | Solution | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 % | Marketed |
| 02200864 | CILOXAN | NOVARTIS PHARMACEUTICALS CANADA INC | Ointment | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 % | Marketed |
| 02252716 | CIPRODEX | NOVARTIS PHARMACEUTICALS CANADA INC | Suspension | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 %; DEXAMETHASONE 0.1 % | Marketed |
| 02353326 | CIPROFLOXACIN | SANIS HEALTH INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02547155 | CIPROFLOXACIN | 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 02547147 | CIPROFLOXACIN | 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02547139 | CIPROFLOXACIN | 10445517 CANADA INC / NORTH PHARMACEUTICALS / DAC PHARMACEUTICALS | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Approved |
| 02353318 | CIPROFLOXACIN | SANIS HEALTH INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02378698 | IPG-CIPROFLOXACIN | MARCAN PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Approved |
| 02380366 | JAMP-CIPROFLOXACIN | JAMP PHARMA CORPORATION | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02380358 | JAMP-CIPROFLOXACIN | JAMP PHARMA CORPORATION | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02423561 | MINT-CIPROFLOX | MINT PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02567636 | NB-CIPROFLOXACIN | NB PHARMA INC. | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02567652 | NB-CIPROFLOXACIN | NB PHARMA INC. | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 02492016 | NRA-CIPROFLOXACIN | NORA PHARMA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 02492008 | NRA-CIPROFLOXACIN | NORA PHARMA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02459655 | OTIXAL | MEDEXUS PHARMACEUTICALS INC. | Solution | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 %; FLUOCINOLONE ACETONIDE 0.025 % | Marketed |
| 02248438 | PMS-CIPROFLOXACIN | PHARMASCIENCE INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02571927 | PRO-CIPROFLOXACIN | PRO DOC LIMITEE | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Approved |
| 02317796 | PRO-CIPROFLOXACIN | PRO DOC LIMITEE | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02317818 | PRO-CIPROFLOXACIN | PRO DOC LIMITEE | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02387131 | SANDOZ CIPROFLOXACIN | SANDOZ CANADA INCORPORATED | Solution | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 % | Marketed |
| 02248757 | SANDOZ CIPROFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02248756 | SANDOZ CIPROFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02248758 | SANDOZ CIPROFLOXACIN | SANDOZ CANADA INCORPORATED | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Marketed |
| 02506882 | SANDOZ CIPROFLOXACIN / DEXAMETHASONE | SANDOZ CANADA INCORPORATED | Suspension | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 %; DEXAMETHASONE 0.1 % | Marketed |
| 02303728 | TARO-CIPROFLOX | SUN PHARMA CANADA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Marketed |
| 02303736 | TARO-CIPROFLOX | SUN PHARMA CANADA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Marketed |
| 02303744 | TARO-CIPROFLOX | SUN PHARMA CANADA INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Marketed |
| 02481901 | TARO-CIPROFLOXACIN/DEXAMETHASONE | TARO PHARMACEUTICALS INC | Suspension | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 0.3 %; DEXAMETHASONE 0.1 % | Marketed |
| 02345188 | CIPROFLOXACIN | COBALT PHARMACEUTICALS COMPANY | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Cancelled Pre Market |
| 02353334 | CIPROFLOXACIN | SANIS HEALTH INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Post Market |
| 02345196 | CIPROFLOXACIN | COBALT PHARMACEUTICALS COMPANY | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Pre Market |
| 02332159 | CIPROFLOXACIN TABLETS | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Pre Market |
| 02332140 | CIPROFLOXACIN TABLETS | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Cancelled Pre Market |
| 02247203 | CIPROFLOXACIN TABLETS USP | DR. REDDY'S LABORATORIES INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Pre Market |
| 02247201 | CIPROFLOXACIN TABLETS USP | DR. REDDY'S LABORATORIES INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Cancelled Pre Market |
| 02247200 | CIPROFLOXACIN TABLETS USP | DR. REDDY'S LABORATORIES INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 100 MG | Cancelled Pre Market |
| 02247202 | CIPROFLOXACIN TABLETS USP | DR. REDDY'S LABORATORIES INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Cancelled Pre Market |
| 02380374 | JAMP-CIPROFLOXACIN | JAMP PHARMA CORPORATION | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Dormant |
| 02379708 | MAR-CIPROFLOXACIN | MARCAN PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Dormant |
| 02423588 | MINT-CIPROFLOX | MINT PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Post Market |
| 02423553 | MINT-CIPROFLOX | MINT PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Cancelled Post Market |
| 02317443 | MINT-CIPROFLOXACIN | MINT PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Post Market |
| 02245648 | MYLAN-CIPROFLOXACIN | MYLAN PHARMACEUTICALS ULC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02445344 | PRIVA-CIPROFLOXACIN | PHARMAPAR INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Cancelled Post Market |
| 02372606 | Q-CIPROFLOXACIN | QD PHARMACEUTICALS ULC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 500 MG | Cancelled Pre Market |
| 02372614 | Q-CIPROFLOXACIN | QD PHARMACEUTICALS ULC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Pre Market |
| 02379643 | SEPTA-CIPROFLOXACIN | SEPTA PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Dormant |
| 02426978 | VAN-CIPROFLOXACIN | VANC PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 250 MG | Cancelled Post Market |
| 02427028 | VAN-CIPROFLOXACIN | VANC PHARMACEUTICALS INC | Tablet | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) 750 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37398 | 2026-04-09 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers. Update to Patient Medication Information. Update to package labels |